{"id":5294,"date":"2011-03-03T17:09:17","date_gmt":"2011-03-03T22:09:17","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=5294"},"modified":"2011-03-03T17:09:17","modified_gmt":"2011-03-03T22:09:17","slug":"a-deep-well","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2011\/03\/03\/a-deep-well\/","title":{"rendered":"a deep well&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\" class=\"entry-header\"><strong><a href=\"http:\/\/pogoblog.typepad.com\/pogo\/2011\/03\/the-national-institutes-of-health-not-friendly-to-ghostwriting.html\" target=\"_blank\">The National Institutes of Health NOT Friendly to Ghostwriting<\/a><br \/>    Project on GovernmentOversight <\/strong><br \/>    By Paul D. Thacker<br \/>    Mar 01, 2011<\/div>\n<p align=\"justify\">Late last year, POGO sent a <strong><a target=\"_blank\" href=\"http:\/\/www.pogo.org\/pogo-files\/letters\/public-health\/ph-iis-20101129.html\">letter<\/a><\/strong>  to the National Institutes of Health (NIH) apprising them of four   examples of academics who used the ghostwriting firm Scientific  Therapeutics  Information to publish studies, letters, and a book.  POGO&rsquo;s letter was <strong><a target=\"_blank\" href=\"http:\/\/www.nytimes.com\/2010\/11\/30\/business\/30drug.html\">covered by <em>The New York Times<\/em><\/a><\/strong>, and <em>Nature<\/em> published an <strong><a target=\"_blank\" href=\"http:\/\/www.nature.com\/nature\/journal\/v468\/n7325\/full\/468732a.html\">editorial<\/a><\/strong> excoriating the NIH for supporting researchers who fail to reveal their  ties to industry.<\/p>\n<p align=\"justify\">Last week, NIH Director Dr. Francis  Collins <strong><a target=\"_blank\" href=\"http:\/\/pogoblog.typepad.com\/pogo\/nih-response-to-pogo-on-ghostwriting-20110217.html\">wrote to POGO<\/a><\/strong>  explaining his agency&rsquo;s take on financial conflicts of interest and   ghostwriting in academia. Presidents and Deans of America&rsquo;s medical  schools take  note: Dr. Collins wrote that the NIH &ldquo;does not condone the  practice of  ghostwriting.&rdquo; In fact, ghostwriting is banned at the NIH,  and if federal funds are involved, Dr. Collins stated that   ghostwriting could be referred to the <strong><a target=\"_blank\" href=\"http:\/\/ori.hhs.gov\/\">Office  of Research Integrity<\/a><\/strong> for an investigation as &ldquo;a case of  plagiarism.&rdquo;<\/p>\n<div align=\"justify\">Dr. Collins also wrote that the NIH is considering ways to deal with  ghostwriting in its newly proposed revision to rules on  conflicts of  interest in extramural funding:<\/div>\n<ul>\n<div align=\"justify\">Because of its potential to  create conflicts-of-interest that could  bias or otherwise inappropriately  influence NIH-supported research,  &ldquo;paid authorship&rdquo; was specifically included in  the proposed revisions  to the regulations. By including &ldquo;paid authorship&rdquo; in  the definition of  &ldquo;Significant Financial Interest&rdquo; in the proposed rule, the  NIH is  sending a clear message to institutions and investigators alike that we   support the principles of transparency and accountability in research  and that institutions and investigators engaging in such activity may be  subject  to more rigorous disclosure and reporting.<\/div>\n<\/ul>\n<div align=\"justify\">People. Pay attention. Time to give up the ghosts.<strong> <\/strong><a target=\"_blank\" href=\"http:\/\/pogoblog.typepad.com\/pogo\/nih-response-to-pogo-on-ghostwriting-20110217.html\"><strong>Read the NIH&rsquo;s response to POGO&rsquo;s letter<\/strong><\/a>.<\/div>\n<\/blockquote>\n<blockquote>\n<div align=\"center\"><strong><a target=\"_blank\" href=\"http:\/\/www.pharmalot.com\/2011\/03\/boo-the-nih-grapples-with-ghostwriting\/\">Boo! The NIH Grapples With Ghostwriting<\/a><br \/>Pharmalot <\/strong><br \/>By Ed Silverman<br \/>March 2nd, 2011<\/div>\n<p align=\"justify\">&#8230; A investigator at the POGO watchdog, however, says the NIH rule may  not go far enough if disclosure does not include payments made to  outsiders who help with the preparation of an article. &ldquo;I don&rsquo;t think he  realizes how extensive [ghostwriting] is. He seems to imply that maybe  there are a few bad apples, but this is how medicine has been proceeding  for a number of years and this is a common practice,&rdquo; says POGO  investigator Paul Thacker who, until recently, was an investigator for  US Senator Chuck Grassley and spearheaded several investigations into  the pharmaceutical industry.<\/p>\n<p align=\"justify\">&ldquo;<strong><font color=\"#200020\">What he doesn&rsquo;t understand are the subtleties &#8211; publications are the  currency in academia. It doesn&rsquo;t matter if the author gets paid or not,  because publication, itself, is compensation. Articles are also used  for gaining tenure and grants. They need to disclose all the money that  goes into publication, all the money spent by a drugmaker to have an  article published, not just what&rsquo;s given a doctor.<\/font><\/strong>&rdquo;<\/p>\n<div align=\"justify\">And to put Collins to the test, Thacker says POGO is currently  investigating an instance that would, in his view, constitute plagiarism  and the watchdog intends to release the information in the coming  weeks. &ldquo;Let&rsquo;s see what happens then,&rdquo; says Thacker.<\/div>\n<\/blockquote>\n<div align=\"justify\">I believe that Thacker is right about Dr. Collins. He&#8217;s a good guy, but he hasn&#8217;t had the &quot;Aha!&quot; moment where he realizes that these professional writers and CROs are producing most of this kind of medical literature on their own and getting authors to sign the product after looking over the galley proofs. Certainly a lot of those Clinical Trial papers about Seroquel were ghost-written [and probably even ghost-researched]. I fear that this is a deeper well than any of us yet realize&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The National Institutes of Health NOT Friendly to Ghostwriting Project on GovernmentOversight By Paul D. Thacker Mar 01, 2011 Late last year, POGO sent a letter to the National Institutes of Health (NIH) apprising them of four examples of academics who used the ghostwriting firm Scientific Therapeutics Information to publish studies, letters, and a book. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-5294","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/5294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=5294"}],"version-history":[{"count":8,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/5294\/revisions"}],"predecessor-version":[{"id":7323,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/5294\/revisions\/7323"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=5294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=5294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=5294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}